Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score

Affiliations

Editorial

Johannes Breyer. Transl Androl Urol. 2017 Oct.

. 2017 Oct;6(5):991-993.

doi: 10.21037/tau.2017.09.06.

¹ Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.
Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, Nawroth R, Schwamborn K, Tulic C, Simic T, Junker K, Harving N, Petersen AC, Jensen JB, Keck B, Grimm MO, Horstmann M, Maurer T, Steyerberg EW, Zwarthoff EC, Real FX, Malats N, Malmström PU, Ørntoft TF. Dyrskjøt L, et al. Eur Urol. 2017 Sep;72(3):461-469. doi: 10.1016/j.eururo.2017.05.040. Epub 2017 Jun 2. Eur Urol. 2017. PMID: 28583312

1. Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017;71:96-108. 10.1016/j.eururo.2016.06.010 - DOI - PubMed
1. Babjuk M, Böhle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2017;71:447-61. 10.1016/j.eururo.2016.05.041 - DOI - PubMed
1. Prout GR, Jr, Barton BA, Griffin PP, et al. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J Urol 1992;148:1413-9. 10.1016/S0022-5347(17)36924-0 - DOI - PubMed
1. Sylvester RJ, van der Meijden A, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-75. 10.1016/j.eururo.2005.12.031 - DOI - PubMed
1. Hong YM, Loughlin KR. Economic impact of tumor markers in bladder cancer surveillance. Urology 2008;71:131-5. 10.1016/j.urology.2007.08.014 - DOI - PubMed